220 related articles for article (PubMed ID: 9017160)
21. [Molecular mechanisms of action of dendrons, containing 48-60 sequence of HIV-1 TAT-protein, on the functional activity of the adenylyl cyclase signaling systems].
Shpakov AO; Gur'ianov IA; Avdeeva EV; Vorob'ev VI; Vlasov GP
Tsitologiia; 2004; 46(11):1011-22. PubMed ID: 15704884
[TBL] [Abstract][Full Text] [Related]
22. Immunomodulatory activity of disulphide bridged peptides related to lactoferrin immunosuppressive mini-domain.
Wieczorek Z; Słoń J; Siemion IZ
Pol J Pharmacol; 1995; 47(5):451-5. PubMed ID: 8868139
[TBL] [Abstract][Full Text] [Related]
23. Interaction of acetylcholinesterase with the G4 domain of the laminin alpha1-chain.
Johnson G; Swart C; Moore SW
Biochem J; 2008 May; 411(3):507-14. PubMed ID: 18215127
[TBL] [Abstract][Full Text] [Related]
24. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5R.
Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
J Med Chem; 2003 Aug; 46(17):3728-33. PubMed ID: 12904077
[TBL] [Abstract][Full Text] [Related]
26. Endothelin (ET)-1-induced inhibition of ATP release from PC-12 cells is mediated by the ETB receptor: differential response to ET-1 on ATP, neuropeptide Y, and dopamine levels.
Gardner A; Westfall TC; Macarthur H
J Pharmacol Exp Ther; 2005 Jun; 313(3):1109-17. PubMed ID: 15687374
[TBL] [Abstract][Full Text] [Related]
27. Immunomodulatory activity of a potent thymopentin analog: disulphide bridged beta-mercaptopropionyl-arginyl-lysyl-aspartyl-valyl-tyrosyl-cysteine amide.
Wieczorek Z; Zimecki M; Trojnar J; Siemion IZ
Pol J Pharmacol; 1996; 48(1):31-8. PubMed ID: 9112625
[TBL] [Abstract][Full Text] [Related]
28. Fasciola gigantica cathepsin L proteinase-based synthetic peptide for immunodiagnosis and prevention of sheep fasciolosis.
Jezek J; El Ridi R; Salah M; Wagih A; Aziz HW; Tallima H; El Shafie MH; Khalek TA; Ammou FF; Strongylis C; Moussis V; Tsikaris V
Biopolymers; 2008; 90(3):349-57. PubMed ID: 17549696
[TBL] [Abstract][Full Text] [Related]
29. Immunosuppressive activity of tyrosine analogues of cyclolinopeptide A.
Wieczorek Z; Pedyczak A; Bodalski T; Lisowski M; Trojnar J; Zimecki M; Siemion IZ
Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):213-6. PubMed ID: 1300986
[TBL] [Abstract][Full Text] [Related]
30. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
[TBL] [Abstract][Full Text] [Related]
31. Development of highly potent and selective dynorphin A analogues as new medicines.
Lung FD; Chen CH; Liu JH
J Pept Res; 2005 Nov; 66(5):263-76. PubMed ID: 16218994
[TBL] [Abstract][Full Text] [Related]
32. New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide.
Grieco P; Carotenuto A; Campiglia P; Gomez-Monterrey I; Auriemma L; Sala M; Marcozzi C; d'Emmanuele di Villa Bianca R; Brancaccio D; Rovero P; Santicioli P; Meini S; Maggi CA; Novellino E
J Med Chem; 2009 Jul; 52(13):3927-40. PubMed ID: 19432421
[TBL] [Abstract][Full Text] [Related]
33. Myotropic effects of new proctolin analogues modified in the position 5 of peptide chain in insects.
Szeszel-Fedorowicz W; Rosiński G; Issberner J; Osborne R; Sliwowska J; Konopińska D
Pol J Pharmacol; 2001; 53(1):31-8. PubMed ID: 11785908
[TBL] [Abstract][Full Text] [Related]
34. Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptide.
Dutta AS; Crowther M; Gormley JJ; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Jamieson A; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
J Pept Sci; 2000 Jul; 6(7):321-41. PubMed ID: 10946997
[TBL] [Abstract][Full Text] [Related]
35. Tetrazole analogues of cyclolinopeptide A: synthesis, conformation, and biology.
Kaczmarek K; Jankowski S; Siemion IZ; Wieczorek Z; Benedetti E; Di Lello P; Isernia C; Saviano M; Zabrocki J
Biopolymers; 2002 May; 63(6):343-57. PubMed ID: 11920436
[TBL] [Abstract][Full Text] [Related]
36. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
[TBL] [Abstract][Full Text] [Related]
37. Cyclization of several linear penta- and heptapeptides with different metal ions studied by CD spectroscopy.
Liu M; Tang YC; Fan KQ; Jiang X; Lai LH; Ye YH
J Pept Res; 2005 Jan; 65(1):55-64. PubMed ID: 15686535
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological activity profile of new analogues of the cyclic opioid peptide H-Tyr-c[D-Cys-Gly-Phe(pNO2)-D-Cys]-NH2 containing (S)-alpha-hydroxymethylcysteine in place of cysteine.
Witkowska R; Chung NN; Schiller PW; Zabrocki J
J Pept Sci; 2005 Jun; 11(6):361-3. PubMed ID: 15635653
[TBL] [Abstract][Full Text] [Related]
39. Purification and structural characterization of insulin and glucagon from the bichir Polypterus senegalis (Actinopterygii: Polypteriformes).
Conlon JM; Fan H; Fritzsch B
Gen Comp Endocrinol; 1998 Jan; 109(1):86-93. PubMed ID: 9446726
[TBL] [Abstract][Full Text] [Related]
40. Effect of tuftsin and its partial sequences on the arterial blood pressure in guinea-pigs.
Paradowski A; Dynowski Z; Kubik A; Siemion IZ
Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):147-52. PubMed ID: 1804045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]